Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000098 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 15, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
21,947
Total Value
$785,384.91
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 3,500 | $6.84 | $23,940.00 | 36,218 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 15, 2026 | Exercise/Conversion | 3,500 | $7.80 | $27,300.00 | 39,718 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 15, 2026 | Sale | 2,384 | $91.10 | $217,173.34 | 37,334 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 15, 2026 | Sale | 3,150 | $92.03 | $289,889.77 | 34,184 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 15, 2026 | Sale | 1,366 | $92.99 | $127,022.70 | 32,818 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 15, 2026 | Sale | 100 | $94.22 | $9,421.72 | 32,718 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 15, 2026 | Sale | 947 | $95.71 | $90,637.37 | 31,771 | Direct | โ | View Details | |
Chief Medical Officer | Employee Stock Option (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 193,563 | Direct | โ | View Details | |
Chief Medical Officer | Employee Warrant (right to buy) | Derivative | Sep 15, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 164,992 | Direct | โ | View Details |